NCT04838938|Completed
Loading search results
Sponsor study identifier
observational
32
1 country
1
Study Start
March 1, 2021
Actual (reported)Primary Completion
March 1, 2022
Actual (reported)Study Completion
July 1, 2023
Actual (reported)The hypothesis underlying this work is the identification of different sub phenotypes of patients with infective endocarditis through the study of the host's response to infection. Furthemore, metagenomic sequencing may be a helpful supplement to IE diagnostic, especially when conventional tests fail to yield a diagnosis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 1, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1, 2021
Actual (reported)March 26, 2021
Actual (reported)April 9, 2021
Actual (reported)March 1, 2022
Actual (reported)July 1, 2023
Actual (reported)To characterize a cohort of patients diagnosed with infective endocarditis
Clinical, microbiological and echocardiographic description of patients with infective endocarditis.
2 year
Identification of the underlying pathogens of infective endocarditis (IE)
2 year
Host response classification for infective endocarditis (IE)
2 year
Host response predictors of sepsis outcomes
2 year
Patients with an active infective endocarditis
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, 33011, Spain
Samples with DNA for the study of the host's sub phenotypes Plasma and heart valves to make a metagenomic sequencing
Guillermo Muñiz Albaiceta, MD, PhD
HUCA-FINBA, Universidad de Oviedo
32 participants (actual enrollment reported by the registry).
First Submitted
March 26, 2021
First Posted
April 9, 2021
Study Start
March 1, 2021
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
March 1, 2022
Actual (reported)Study Completion
July 1, 2023
Actual (reported)Last Updated
October 5, 2023
Record last verified: 2023-10
All datasets underlying the study are available upon request to the study principal investigator. All of the individual participant data collected during the trial, informed consent forms, study protocol, statistical analysis plan and raw data, are available under reasonable request, and after deindentification.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: